The global lung cancer screening software market size is expected to reach USD 45.0 million by 2030, registering a CAGR of 6.9% from 2024 to 2030. Growing incidence of lung cancer and rise in implementation of lung cancer screening programs across the globe are some of the significant factors driving the market growth. According to Globocan estimates, about 160,068 new cases of lung cancer were reported in South East Asian region in 2018.
A number of clinical trials, studies, and demonstration projects are being conducted around the world to evaluate the effectiveness of lung cancer screening programs. For instance, in 2017, Cancer Care Ontario launched a screening pilot trial for people at high risk. Favorable government initiatives for successful implementation of such programs and increasing awareness about the disease screening are also likely to contribute to the market growth in the coming years.
Lung cancer screening programs are widely adopted by hospitals and radiological centers in U.S. However, they are usually performed as a part of national or provisional screening program outside the country. In case of Latin America and Middle Eastern countries, limited availability of resources, restricted funding, low awareness levels, and lack of trained personnel are some of the factors that impede market growth.
This product will be delivered within 1-3 business days.
A number of clinical trials, studies, and demonstration projects are being conducted around the world to evaluate the effectiveness of lung cancer screening programs. For instance, in 2017, Cancer Care Ontario launched a screening pilot trial for people at high risk. Favorable government initiatives for successful implementation of such programs and increasing awareness about the disease screening are also likely to contribute to the market growth in the coming years.
Lung cancer screening programs are widely adopted by hospitals and radiological centers in U.S. However, they are usually performed as a part of national or provisional screening program outside the country. In case of Latin America and Middle Eastern countries, limited availability of resources, restricted funding, low awareness levels, and lack of trained personnel are some of the factors that impede market growth.
Lung Cancer Screening Software Market Report Highlights
- In 2023, North America accounted for the highest revenue share owing to various lung cancer screening programs and favorable reimbursement scenario in the region
- Asia Pacific is expected to be the fastest-growing regional market over the forecast period
- This is attributed to the increasing cases of lung cancer and rise in the number of screening trials & studies for the disease
The leading players in the Lung Cancer Screening Software market include:
- Nuance Communications, Inc.
- Eon
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Voxel Cloud
- MRS
- PENRAD
- MagView
- FUJIFILM Holdings Corporation
- Medtronic
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Lung Cancer Screening Software Market Variables, Trends, & Scope
Chapter 4. Lung Cancer Screening Software Market: Regional Estimates & Trend Analysis
Chapter 5. Competitive Landscape
Companies Mentioned
The leading players in the Lung Cancer Screening Software market include:- Nuance Communications, Inc.
- Eon
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Voxel Cloud
- MRS
- PENRAD
- MagView
- FUJIFILM Holdings Corporation
- Medtronic
Methodology
LOADING...
